Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pierre Fabre presents new protein prenyltransferase inhibitors

June 10, 2002

PI-88 plus Taxotere to be evaluated in phase I trial

June 7, 2002

Phase Ib trial evaluating CA4P in combination with carboplatin in advanced solid tumors

June 7, 2002

Phase II dose of orally active MEK inhibitor selected from phase I studies

June 7, 2002

Acceptable safety and PK profile emerges from ongoing phase I trial of EKB-569

June 7, 2002

A phase I trial in patients with advanced solid tumors shows the safety and efficacy of BMS-214662

June 7, 2002

Phase III trial of RSR-13 in brain metastases continues following interim review

June 7, 2002

AES-14 reduces severe mucositis in acute radiation model

June 7, 2002

Maximum tolerated dose identified for AP-5280

June 7, 2002

AstraZeneca presents novel Src kinase inhibitors

June 7, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...